Compare Medpace Holdings Inc (MEDP) vs iShares 1 3 Year Treasury Bond ETF (SHY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs iShares 1 3 Year Treasury Bond ETF — how do they compare? Medpace Holdings Inc trades at $612.05 (market cap $16.82B), while iShares 1 3 Year Treasury Bond ETF trades at $81.2 (market cap $26.68B). The key difference: iShares 1 3 Year Treasury Bond ETF is the larger of the two by market cap, and Medpace Holdings Inc is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and iShares 1 3 Year Treasury Bond ETF for 63 Days on average.
| MEDP | SHY | |
|---|---|---|
Market Cap | $16.82B | $26.68B |
Volume | 223,093 | 4,077,691 |
Sector | Health | Fixed Income |
52-Week High | $630.19 | $83.18 |
52-Week Low | $393.42 | $81.05 |
Typical Hold Time | 14 Days | 63 Days |
Enterprise Value | $16.44B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $602.70, down 0.26% with neutral technical signals. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (17.67% net margin, 162.15% ROE). Recent CEO stock sales and mixed institutional activity create near-term uncertainty, though analyst consensus remains positive with a $620.44 price target. The company is scheduled to report Q3 2026 results on October 21, 2026.
MEDP presents a compelling growth story with strong financial metrics, though elevated valuations (P/E 35.41) and insider selling warrant caution. Upside potential exists if Q3 earnings meet expectations, while failure to maintain growth momentum could pressure the stock. The current price near pivot point ($599) suggests balanced risk-reward ahead of earnings.
SHY, a US stock, trades at $81.20 with minimal daily movement (+0.05%). The technical outlook is bearish, with moving averages signaling downward pressure and key indicators like the ADX_12 at 50.39 suggesting a strong trend. Recent corporate actions include scheduled dividends through late 2026, though financial ratios (P/E, P/S, etc.) are unavailable in the current snapshot. Market sentiment is influenced by broader bond market volatility, with news highlighting rising Treasury yields and geopolitical tensions impacting inflation expectations.
The outlook for SHY is cautious amid a bearish technical setup and macroeconomic headwinds, including higher interest rates and inflation concerns. Opportunities may arise from its dividend payments, but risks include sustained bond market sell-offs and economic uncertainty. Investors should weigh the stock's stability against potential volatility from external factors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About iShares 1 3 Year Treasury Bond ETF
SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →
